Clinical trials have started on a drug called HOPO 14-1, which has the potential to remove radioactive particles from the body. The drug works as a chelator, meaning it grabs onto toxic metals and removes them from the body. Unlike previous options for treating radiation poisoning, HOPO 14-1 does not remove essential minerals from the body and can be administered orally rather than intravenously. The drug is currently in Phase 1 trials to test its safety in humans. It may also have potential applications for removing other toxic metals, such as lead and cadmium, and for preventing the deposition of gadolinium in the body after an MRI.
Mon, 31 Jul 2023 06:02:29 GMT | National Geographic